ロード中...
Targeting EGFR in Esophagogastric Cancer
Esophagogastric cancer (EGC) remains a major cause of cancer-related mortality. Overall survival in the metastatic setting remains poor, with few molecular targeted approaches having been successfully incorporated into routine care to-date: only first line anti-HER2 therapy in ERBB2-expressing tumor...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753114/ https://ncbi.nlm.nih.gov/pubmed/33364187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.553876 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|